Expression Genetics, Inc.
Expression Genetics, Inc. (Egen)is a pharmaceutical company engaged in the development of therapeutics for the treatment of human diseases including cancer and cardiovascular disease. The company specializes in nucleic acid (DNA and RNAi) delivery and therapeutics aimed at specific disease targets. Its product pipeline includes products targeted at the treatment of various cancers and cardiovascular disease involving siRNA, shRNA, tumor antigens, and angiogenic genes. It has developed a proprietary technology called TheraPlas an effective immunotherapy for treating various types of tumors when utilized in combination with an Interleukin-12 plasmid. The company has entered into collaboration with many investigators, biotech organizations and universities to further develop its products. The company is headquartered in Huntsville, the US.